期刊文献+

肺癌患者外周血调节性T细胞检测的临床意义 被引量:4

Clinical significance of regulatory T cell in peripheral blood in patients with lung cancer
下载PDF
导出
摘要 目的:探讨肺癌患者外周血调节性T细胞(CD4+CD25+FoxP3+,Treg细胞)的变化及其与病理参数的相关性。方法:应用流式细胞仪检测56例肺癌患者和18名健康对照者(健康对照组)外周血单个核细胞(PBMC)中Treg细胞占CD4+T细胞的百分率,分析其与年龄、性别、肺癌分期、病理类型以及是否合并胸腔积液等的关系。结果:①肺癌患者外周血Treg细胞百分率高于健康对照组[(6.15±3.15)%比(3.65±2.48)%,P<0.01]。早期组(TNM分期:Ⅰa期~Ⅲa期)[(5.04±2.40)%]、晚期组(TNM分期:Ⅲb期~Ⅳ期)[(6.83±3.09)%]分别与健康对照组[(3.65±2.48)%]比较,Treg细胞百分率均明显升高(P<0.01)。②晚期肺癌患者中,非老年组(年龄≤60岁,12例)患者外周血Treg细胞较老年组(年龄>60岁,26例)明显升高[(8.79±3.49)%比(4.86±2.69)%],差异有统计学意义(P<0.01)。③根据病理类型分为非小细胞肺癌52例(18例鳞癌、34例腺癌),小细胞肺癌4例,非小细胞肺癌患者外周血中Treg细胞百分率较小细胞肺癌有增高趋势[(6.44±3.16)%比(3.44±1.97)%],但尚无统计学意义(P>0.05)。④肺癌患者外周血中Treg细胞百分率与性别、有无胸水无相关性(P>0.05)。⑤回归分析显示晚期肺癌患者外周血中Treg百分率与年龄呈负相关(P<0.05)。结论:肺癌患者处于免疫抑制状态,其外周血中Treg细胞百分率与肺癌分期、年龄有关。 Objective To investigate the correlation between changes of regulatory T cells in peripheral blood and clinicopathological parameters in patients with lung cancer.Methods The CD4+CD25+FoxP3+ regulatory T cell (Treg) in peripheral blood of 56 lung cancer patients and 18 healthy controls were measured by flow cytometry,and the correlation between percentage of Treg in PBMC and clinical pathologic parameters of lung cancer such as cancer stage,age of patient,gender,pathologic type and complicated pleural effusion were analyzed.Results ① The percentage of Treg in lung cancer patients was significantly higher than that in healthy controls [(6.15± 3.15)% vs (3.65±2.48)%,P0.01].We compared seperately the percentage of Treg in early stage and late stage lung cancer with those in health controls,the results showed that the Treg percentage in both early and late stage lung cancer patients [(5.04±2.40)% and (6.83±3.09) %] were much higher than that in healthy controls [(3.65±2.48)%](P0.01).② In the late stage (TNMⅠa-Ⅲa),the Treg percentage in non-elderly patients was higher than that in elderly patients [(8.79±3.49)% vs (4.86±2.69)%,P0.05].③ There was no significant difference of Treg percentage between various pathological types of lung cancer (P0.05),although the Treg percentage of non-small cell lung cancer was somewhat higher than those of small cell lung cancer.④ There was no difference of Treg percentage between male and female,and with or without pleural effusion.⑤ Regression analysis showed that,in late stage lung cancer,Treg percentage had a negative correlation with age.Conclusions The patients with lung cancer are under immune suppressed status,and the Treg percentage has some correlation with tumor stage and age.
出处 《诊断学理论与实践》 2010年第3期260-263,共4页 Journal of Diagnostics Concepts & Practice
基金 仁济医院-基础医学院合作研究基金(PY07011)
关键词 肺肿瘤 外周血调节性T细胞 检测 Lung neoplasms Regulatory T cell in peripheral blood Detection
  • 相关文献

参考文献16

  • 1Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4+CD25+regulatory T cells[J].Nat Immunol,2003,4(4):330-336.
  • 2Nakamura K,Kitani A,Strobor W.Cell contact-dependent immunosuppression by CD4(+)CD25(+)regulatory T cells is mediated by cell surface-bound transforming growth factor beta[J].J Exp Med,2001,194(5):629-644.
  • 3Born WK,Reardon CL,O'Brien RL.The funotion of gammadelta T cells in innate immunity[J].Curr Opin Immunol.2006,18(1):31-38.
  • 4Moser B,Brandes M.Gammadelta T cells:an alternative type of professional APC[J].Trends Immunol,2006,27(3):112-118.
  • 5Staveley-O'Carroll K,Sotomayor E,Montgomery J,et al.Induction of antigen-specific T cell anergy:An early event in the course of tumor progression[J].Proc Natl Acad Sci USA,1998,95(3):1178-1183.
  • 6Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995.155(3):1151-1164.
  • 7Baecher-Allan C,Brown JA,Freeman GJ,et al.CD4+CD25high regulatory cells in human peripheral blood[J].J Immunol,2001,167(3):1245-1253.
  • 8Sakaguchi S.Regulatory T cells:key controllers of immunologic self-tolerance[J].Cell,2000,101(5):455-458.
  • 9Jones E,Dahm-Vicker M,Colsher D,et al.CD25+ regulatory T cells and tumor immunity[J].Immunol Lett,2003,85(2):141-143.
  • 10刘莉,丁乾,曹如波,王晶,姚军霞,黄士昂.恶性肿瘤患者外周血CD4^+ CD25^+调节T细胞的检测及其临床意义[J].临床肿瘤学杂志,2005,10(4):342-345. 被引量:16

二级参考文献8

  • 1Itoh M, Takahashi T, Sakaguchi, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance[J]. J Immunol,1999,162(9):5317-5326.
  • 2Seo N, Hayakawa S, Takigawa M, et al. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity[J]. Immunology, 2001,103(4):449-457.
  • 3Rosenberg SA. Progress in human tumour immunology and immunotherapy[J]. Nature, 2001,411:380-384.
  • 4Seitz J, Bruck J, Lenz J, et al. Deletion of CD4+ CD25+ T cells and treatment with tyrosinase-related protein2-transduced dendritic cells enhance the interferon alpha-induced, CD8+ T-cell-dependent immune defense of B16 melonoma[J]. Cancer Res, 2001,61:8643-8646.
  • 5Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses[J]. J Exp Med,2001,194(6):823-832.
  • 6Tanaka H, Tanaka J, Kjaergaard J, et al. Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes[J]. J Immunother,2002,25(3):207-217.
  • 7Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients[J]. Clin Cancer Res,2003,9(2):606-612.
  • 8Sasada T, Kimura M, Yoshida Y, et al. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression[J]. Cancer, 2003,98(5):1089-1099.

共引文献15

同被引文献41

  • 1陈广洁.Foxp3和CD4^+CD25^+调节性T细胞研究进展[J].国外医学(免疫学分册),2005,28(1):1-4. 被引量:15
  • 2Smyth LJ, Starkey C, Vestbo J, et al. CD4-regulatory cells in COPD patients[J]. Chest, 2007,132 : 156-168.
  • 3Barcelo B, Pons J, Ferrer JM, et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+ CD25+ regulatory T-lymphocyte response to tobacco smoking[J]. Eur Respir J,2008,31 :555-562.
  • 4Plumb J, Smyth LJ, Adams HR, et al. Increased T-regulatory cells within lymphocyte follicles in moderate COPD[J]. Eur Respir J, 2009,34 : 89-94.
  • 5Isajevs S, Taivans I, Strazda G, et al. Decreased FOXP3 expression in small airways of smokers with COPD[J]. Eur Respir J,2009,33:61- 67.
  • 6Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema[J]. Nat Med,2007,13:567-569.
  • 7Choi IS. Immune tolerance by induced regulatory T cells in asthma[J]. Allergy Asthma Immunol Res,2012,4:113-115.
  • 8Abdulamir AS, Kadhim HS, Hafidh RR, et al. Severity of asthma: the role of CD25^+ , CD30^+ , NF kappaB, and apoptotic markers[J]. J Investig Allergol Clin lmmunol, 2009,19 : 218-224.
  • 9Smyth LJ, Eustace A, Kolsum U, et al. Increased airway T regulatory cells in asthmatic subjects[J]. Chest, 2010,138: 905- 912.
  • 10Geffner L, Basile JI, Yokobori N, et al. CD4?^+ CD25high Foxp3^+ regulatory T lymphocytes suppress IFNγ and CD107 expression in CD4^+ and CD8^+ T cells from tuberculous pleural effusions[J]. Clin Exp Immunol, 2013.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部